Cargando…

Association of the Apolipoprotein E 2 Allele with Concurrent Occurrence of Endometrial Hyperplasia and Endometrial Carcinoma

Genes encoding proteins with antioxidant properties may influence susceptibility to endometrial hyperplasia (EH) and endometrial carcinoma (ECa). Patients with EH (n = 89), EH concurrent with ECa (n = 76), ECa (n = 186), and healthy controls (n = 1110) were genotyped for five polymorphic variants in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ivanova, Tatiana I., Krikunova, Ludmila I., Ryabchenko, Nikolay I., Mkrtchyan, Liana S., Khorokhorina, Vera A., Salnikova, Lyubov E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4337044/ https://www.ncbi.nlm.nih.gov/pubmed/25741405 http://dx.doi.org/10.1155/2015/593658

Ejemplares similares

Concurrent and future risk of endometrial cancer in women with endometrial hyperplasia: A systematic review and meta-analysis
por: Doherty, Michelle T., et al.
Publicado: (2020)

PTEN Sequence Analysis in Endometrial Hyperplasia and Endometrial Carcinoma in Slovak Women
por: Gbelcová, H., et al.
Publicado: (2015)

Multimodal MRI-Based Radiomics-Clinical Model for Preoperatively Differentiating Concurrent Endometrial Carcinoma From Atypical Endometrial Hyperplasia
por: Zhang, Jieying, et al.
Publicado: (2022)

Endometrial hyperplasia as a risk factor of endometrial cancer
por: Nees, Lisa K., et al.
Publicado: (2022)

Concurrent occurrence of granulosa cell tumor, uterine adenomyosis, cystic endometrial hyperplasia and uterine serosal inclusion cyst in a bitch
por: Sabiza, Soroush, et al.
Publicado: (2020)

Expression of the VEGF and angiopoietin genes in endometrial atypical hyperplasia and endometrial cancer
por: Holland, C M, et al.
Publicado: (2003)

Progestin Resistance and Corresponding Management of Abnormal Endometrial Hyperplasia and Endometrial Carcinoma
por: Lv, Mu, et al.
Publicado: (2022)

Rapid identification of endometrial hyperplasia and endometrial endometrioid cancer in young women
por: Kuai, Dan, et al.
Publicado: (2023)

Prognostic Value of Serum Transferrin Analysis in Patients with Ovarian Cancer and Cancer-Related Functional Iron Deficiency: A Retrospective Case–Control Study
por: Ivanova, Tatiana I., et al.
Publicado: (2022)

Endometrial Stromal Hyperplasia: An Underrecognized Condition
por: Sivridis, Efthimios, et al.
Publicado: (2013)

Genomic imbalance in endometrial hyperplasia and cancer
por: Bednarek, Michal, et al.
Publicado: (2015)

Therapeutic options for management of endometrial hyperplasia
por: Chandra, Vishal, et al.
Publicado: (2016)

Quantitative contrast-enhanced ultrasonography for the differential diagnosis of endometrial hyperplasia and endometrial neoplasms
por: Liu, Ying, et al.
Publicado: (2016)

Risk factors of endometrial cancer in patients with endometrial hyperplasia: implication for clinical treatments
por: Zhao, Jie, et al.
Publicado: (2021)

Fertility-Sparing Treatment for Endometrial Cancer or Atypical Endometrial Hyperplasia Patients With Obesity
por: Chen, Junyu, et al.
Publicado: (2022)

Laparoscopic Surgery for Atypical Endometrial Hyperplasia with Awareness Regarding the Possibility of Endometrial Cancer
por: Kamii, Misato, et al.
Publicado: (2022)

Menopausal Status Combined with Serum CA125 Level Significantly Predicted Concurrent Endometrial Cancer in Women Diagnosed with Atypical Endometrial Hyperplasia before Surgery †
por: Lou, Yaochen, et al.
Publicado: (2021)

Role of Morphometry and Matrix Metalloproteinase-9 Expression in Differentiating between Atypical Endometrial Hyperplasia and Low Grade Endometrial Adenocarcinoma
por: Assaf, Magda I, et al.
Publicado: (2018)

Assessment of endometrial receptor systems for PPPM approach for endometrial hyperplasia in reproductive age women
por: Goncharenko, Vadym M, et al.
Publicado: (2014)

Endometrial evaluation with transvaginal ultrasonography for the screening of endometrial hyperplasia or cancer in premenopausal and perimenopausal women
por: Kim, Min-Jeong, et al.
Publicado: (2016)

Risk Assessment of Endometrial Hyperplasia or Endometrial Cancer with Simplified Ultrasound-Based Scoring Systems
por: Stachowicz, Norbert, et al.
Publicado: (2021)

Diagnostic Accuracy of Hysteroscopic Scoring System in Predicting Endometrial Malignancy and Atypical Endometrial Hyperplasia
por: Harika, Bhukya, et al.
Publicado: (2021)

Conservative Management of Atypical Endometrial Hyperplasia and Early Endometrial Cancer in Childbearing Age Women
por: Uccella, Stefano, et al.
Publicado: (2022)

Value of endometrial thickness for the detection of endometrial cancer and atypical hyperplasia in asymptomatic postmenopausal women
por: Zhang, Linna, et al.
Publicado: (2022)

Metformin for endometrial hyperplasia: a Cochrane protocol
por: Clement, Naomi S, et al.
Publicado: (2016)

Lymph node dissection in atypical endometrial hyperplasia
por: Taşkın, Salih, et al.
Publicado: (2017)

The value of MRI in management of endometrial hyperplasia with atypia
por: Natarajan, Purushothaman, et al.
Publicado: (2020)

The Value of Vaginal Microbiome in Patients with Endometrial Hyperplasia
por: Zhang, Hu, et al.
Publicado: (2021)

Radiation Response of Cervical Cancer Stem Cells Is Associated with Pretreatment Proportion of These Cells and Physical Status of HPV DNA
por: Zamulaeva, Irina, et al.
Publicado: (2021)

Personalized treatment strategy for atypical endometrial hyperplasia with regards to age, comorbidities and endometrial receptor status
por: Goncharenko, Vadym M, et al.
Publicado: (2014)

The incidence rates of endometrial hyperplasia and endometrial cancer: a four-year population-based study
por: Yuk, Jin-Sung
Publicado: (2016)

Pregnancy outcomes of women who received conservative therapy for endometrial carcinoma or atypical endometrial hyperplasia
por: Matsuzaki, Toshiya, et al.
Publicado: (2018)

Progestin Intrauterine Devices and Metformin: Endometrial Hyperplasia and Early Stage Endometrial Cancer Medical Management
por: Nwanodi, Oroma
Publicado: (2017)

miRNAs as Candidate Biomarker for the Accurate Detection of Atypical Endometrial Hyperplasia/Endometrial Intraepithelial Neoplasia
por: Giglio, Simona, et al.
Publicado: (2019)

Risk factors of progression to endometrial cancer in women with endometrial hyperplasia: A retrospective cohort study
por: Jeong, Jin Young, et al.
Publicado: (2020)

Endometrial Metaplastic/Reactive Changes Coexistent with Endometrial Hyperplasia and Carcinoma: A Morphological and Immunohistochemical Study
por: Travaglino, Antonio, et al.
Publicado: (2021)

The present status of metformin in fertility-preserving treatment in atypical endometrial hyperplasia and endometrioid endometrial cancer
por: Guan, Jun, et al.
Publicado: (2022)

A Case of Cushing's Syndrome Presenting as Endometrial Hyperplasia
por: Lee, Sang Min, et al.
Publicado: (2008)

Neutrophil-lymphocyte and platelet-lymphocyte ratios in endometrial hyperplasia
por: Cakmak, Bulent, et al.
Publicado: (2015)

New concepts for an old problem: the diagnosis of endometrial hyperplasia
por: Sanderson, Peter A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_r1f52l9u93g2oe933aqbm68hpn